It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and ...

A police officer keeps an eye on the crowd, while transgender flags fly, in Washington, D.C., U.S., January 13, 2026. REUTERS/Kevin Lamarque The U.S. Department of Justice has agreed to withdraw a ...

Gilead Sciences' already dominant position in HIV pre-exposure prophylaxis (PrEP) could be extended if the FDA approves a new twice-yearly product later this year. The US regulator has started a ...